// App-Quantinova.ai

M5052 2016 AHA : Delayed Ticagrelor Pharmacodynamic Effect in ACS in the Absence of Morphine Therapy and Hemodynamic Compromise

Researchers

Presenter

  • Udaya Tantry

Principal Investigators

  • Dennis Emuron

  • Rahul Chaudhary

  • Paul Gurbel

Medical Centers

  • Sinai Hospital of Baltimore, Baltimore, MD

  • Inova Heart and Vascular Inst, Falls Church, VA

  • Sinai Hospital of Baltimore, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Stable coronary artery disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Ticagrelor

  • Morphine

  • D-morphine

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved